相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes sternness in mammary epithelial cells
Eunhye Oh et al.
CELLULAR SIGNALLING (2017)
Disulfiram suppresses cancer stem-like properties and STAT3 signaling in triple-negative breast cancer cells
Yoon-Jae Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Disulfiram induces anoikis and suppresses lung colonization in triple- negative breast cancer via calpain activation
Ji Young Kim et al.
CANCER LETTERS (2017)
Constitutive activation of STAT3 in breast cancer cells: A review
Kasturi Banerjee et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis
Eunhye Oh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer
Ji Young Kim et al.
CANCER LETTERS (2016)
STAT3 as a potential therapeutic target in ALDI+ and CD44+/CD24+ stem cell-like pancreatic cancer cells
Li Lin et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro
Vera Kralova et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)
ALDH1A1 induces resistance to CHOP in diffuse large B-cell lymphoma through activation of the JAK2/STAT3 pathway
Jinqiong Jiang et al.
ONCOTARGETS AND THERAPY (2016)
Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
Murugan Kalimutho et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer
Ravi Thakur et al.
SCIENTIFIC REPORTS (2015)
Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells
Hyunsook An et al.
PLOS ONE (2015)
The fate of chemoresistance in triple negative breast cancer (TNBC)
Elma A. O'Reilly et al.
BBA CLINICAL (2015)
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
Khalid Abubaker et al.
BMC CANCER (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Vimentin as a poor prognostic factor for triple-negative breast cancer
Nami Yamashita et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Evaluation of STAT3 Signaling in ALDH plus and ALDH+/CD44+/CD24-Subpopulations of Breast Cancer Cells
Li Lin et al.
PLOS ONE (2013)
Role of STAT3 in Cancer Metastasis and Translational Advances
Mohammad Zahid Kamran et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis
Qing Chang et al.
NEOPLASIA (2013)
Breast cancer stem cells: treatment resistance and therapeutic opportunities
Fares Al-Ejeh et al.
CARCINOGENESIS (2011)
Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs
Charles D. Mackenzie et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
Sara Ricardo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Initial steps of metastasis: Cell invasion and endothelial transmigration
Franziska van Zijl et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2011)
Triple-Negative Breast Cancer: An Unmet Medical Need
Clifford A. Hudis et al.
ONCOLOGIST (2011)
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma
Paul A. Spagnuolo et al.
BLOOD (2010)
Triple-Negative Breast Cancer Role of Specific Chemotherapy Agents
Steven J. Isakoff
CANCER JOURNAL (2010)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer
PS Patel et al.
INDIAN JOURNAL OF CANCER (2009)
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Bin-Bing S. Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Flubendazole in cystic echinococcosis therapy: Pharmaco-parasitological evaluation in mice
Laura Ceballos et al.
PARASITOLOGY INTERNATIONAL (2009)
Opinion - Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
John Stingl et al.
NATURE REVIEWS CANCER (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis
TX Xie et al.
ONCOGENE (2004)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
DY Wei et al.
ONCOGENE (2003)
分享论文
